Thus, bacterial lithocholic acid (LCA) application notably reduced proliferation, VEGF production, aggressiveness, and metastatic potential of breast cancer cells by stimulating the antitumor immune response and mesenchymal-to-epithelial-transition [50]. Here, VEGFA is linked to breast cancer.